Carme Pedro

Cytogenetic risk stratification in chronic myelomonocytic leukemia

Esperanza Such, J. Cervera, Dolors Costa et al. · Haematologica · 2010 · 264 citations · Full text

Life Sciences, Hematology, Oncology +15

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

Mar Mallo, José Cervera, Julie Schanz et al. · Leukemia · 2010 · 120 citations · Full text

Life Sciences, Genetics, Hematology +17

Independent Impact of Iron Overload and Transfusion Dependency on Survival and Leukemic Evolution in Patients with Myelodysplastic Syndrome

Guillermo Sanz, Benet Nomdedeu, Esperanza Such et al. · Blood · 2008 · 116 citations

Medicine, Hematology, Oncology +17

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

Andrea Kuendgen, Meritxell Nomdedéu, Heinz Tuechler et al. · Leukemia · 2020 · 74 citations · Full text

Medicine, Oncology, Clinical Classification Systems +16

Reversible Coma Secondary to Cefepime Neurotoxicity

Sergio Abanades, Juan Nolla, Ana Rodríguez-Campello et al. · Annals of Pharmacotherapy · 2004 · 56 citations

Medicine, Neurology, Pharmacotherapy +13